Reply to the letter: Biotinidase deficiency masquerading as multiple sclerosis?Multiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Dynamic volumetric changes of hippocampal subfields in clinically isolated syndrome patients: A 2-year MRI study
Dynamic volumetric changes of hippocampal subfields in clinically isolated syndrome patients: A 2-year MRI studyMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Watch How Street Artist Lydiaemily is Making Her Mark on Ending MS Forever/About-the-Society/News/Watch-How-Street-Artist-Lydiaemily-is-Making-Her-M … read morePosted At: National MS Society
Results Published from Phase II Trial of Daclizumab in Relapsing MS/About-the-Society/News/Results-Published-from-Phase-II-Trial-of-Daclizuma … read morePosted At: National MS Society
Nose2Brain: Better therapy for multiple sclerosisMedically active substances are normally distributed via the blood — either directly by injection into the bloodstream or indirectly, for example through the digestive tract after oral administration. In...
- Next story What is your “one day” wish for a life with multiple sclerosis?
- Previous story Emerging Therapies, Wellness, Progression and Other MS Research News from AAN Meeting
Join Our Mailing List
- World’s Largest MS Research Conference: Understanding MS and New Strategies to Restore Function
- Conceptual framework to study role of exercise in multiple sclerosis
- Insights into microbiome research 3: Who’s there versus what are they doing?
- Updates From ECTRIMS Research Conference
- Environmental factors may trigger onset of multiple sclerosis
- Genetic Ancestry Associated with Clinical Course in Hispanic-Latinos: Study is Ongoing
- Prognostic information for people with MS: Impossible or inevitable?
- New immunotherapy targeting blood-clotting protein
- Animal models of multiple sclerosis: From rodents to zebrafish
- Inclusion criteria used in trials of people with progressive multiple sclerosis